Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting

Detalles Bibliográficos
Autores principales: Wang, Tiansheng, Lu, Wenchao, Li, Dandan, Tang, Huilin, Yang, Jeff Y., Buse, John B., Stürmer, Til
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2019
Materias:
e-Letters: Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118246/
https://www.ncbi.nlm.nih.gov/pubmed/31110120
http://dx.doi.org/10.2337/dc18-1609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118246/
https://www.ncbi.nlm.nih.gov/pubmed/31110120
http://dx.doi.org/10.2337/dc18-1609

Ejemplares similares